We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
126
Honeywell
HON
$63.8B
$4.56M 0.01%
22,841
-973
-4% -$197K
ET icon
127
Energy Transfer Partners
ET
$74B
$4.55M 0.01%
245,013
+60,957
+33% +$1.19M
RACE icon
128
Ferrari
RACE
$71.9B
$4.29M 0.01%
10,020
+1,871
+23% +$841K
WFC icon
129
Wells Fargo
WFC
$268B
$4.08M 0.01%
56,853
CSX icon
130
CSX Corp
CSX
$90.6B
$3.94M 0.01%
133,884
EMR icon
131
Emerson Electric
EMR
$82.7B
$3.86M 0.01%
35,170
CNP icon
132
CenterPoint Energy
CNP
$25.5B
$3.65M 0.01%
100,766
+2,000
+2% +$67K
EQIX icon
133
Equinix
EQIX
$98.5B
$3.64M 0.01%
4,461
TRGP icon
134
Targa Resources
TRGP
$61.6B
$3.55M 0.01%
17,719
+8,600
+94% +$1.71M
YUMC icon
135
Yum China
YUMC
$14.5B
$3.33M 0.01%
63,876
+3,366
+6% +$161K
NVS icon
136
Novartis
NVS
$264B
$3.23M 0.01%
28,936
-5,650
-16% -$601K
FOX icon
137
Fox Class B
FOX
$25.7B
$2.99M 0.01%
56,644
-598
-1% -$29.7K
FISV
138
Fiserv Inc
FISV
$27.1B
$2.95M 0.01%
13,344
-200
-1% -$43.8K
CL icon
139
Colgate-Palmolive
CL
$70.1B
$2.7M 0.01%
28,788
-3,836
-12% -$343K
WYNN icon
140
Wynn Resorts
WYNN
$9.04B
$2.57M 0.01%
30,750
MDT icon
141
Medtronic
MDT
$120B
$2.52M 0.01%
28,095
-4,000
-12% -$358K
DKNG icon
142
DraftKings
DKNG
$12.3B
$2.51M 0.01%
75,500
CPT icon
143
Camden Property Trust
CPT
$12B
$2.32M 0.01%
18,950
MPLX icon
144
MPLX
MPLX
$59.7B
$2.29M 0.01%
42,775
+21,961
+106% +$1.15M
SLB icon
145
SLB Ltd
SLB
$79.1B
$2.27M 0.01%
54,418
-700
-1% -$28.7K
STZ icon
146
Constellation Brands
STZ
$21.3B
$2.27M 0.01%
12,350
-3,040
-20% -$552K
TMO icon
147
Thermo Fisher Scientific
TMO
$227B
$2.19M 0.01%
4,403
-239
-5% -$129K
CSCO icon
148
Cisco
CSCO
$434B
$2.19M 0.01%
35,426
-152
-0.4% -$9.36K
CMI icon
149
Cummins
CMI
$74.5B
$2.17M 0.01%
6,909
-1,286
-16% -$453K
AMD icon
150
Advanced Micro Devices
AMD
$805B
$2.13M 0.01%
20,712
+2,010
+11% +$223K

Similar funds

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.